Australia's CSL Loses Major Opponent In Plasma Price-fixing Suit
This article was originally published in PharmAsia News
Executive Summary
CSL of Australia lost one of the participants in a multimillion-dollar antitrust suit involving blood plasma when the U.S.-based Mayo Clinic dropped out